![Regine Brokamp](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Regine Brokamp
Direttore operativo presso Selexis SA
Posizioni attive di Regine Brokamp
Società | Posizione | Inizio | Fine |
---|---|---|---|
Selexis SA
![]() Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Direttore operativo | - | - |
Storia della carriera di Regine Brokamp
Precedenti posizioni note di Regine Brokamp
Società | Posizione | Inizio | Fine |
---|---|---|---|
Max-Planck-Institute for Molecular Genetics | Corporate Officer/Principal | - | - |
Micromet AG
![]() Micromet AG Pharmaceuticals: MajorHealth Technology Micromet AG developed, manufactured and marketed novel antibody derived therapeutics for the treatment and control of cancer, inflammatory and autoimmune diseases. It's goal was to commercialize products in these indication areas that have significant unmet medical needs. Founded in 1993, the company was headquartered in Munich, Germany. | Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
Germania | 3 |
Svizzera | 2 |
Posizioni
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Settori
Commercial Services | 2 |
Health Technology | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Selexis SA
![]() Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Commercial Services |
Micromet AG
![]() Micromet AG Pharmaceuticals: MajorHealth Technology Micromet AG developed, manufactured and marketed novel antibody derived therapeutics for the treatment and control of cancer, inflammatory and autoimmune diseases. It's goal was to commercialize products in these indication areas that have significant unmet medical needs. Founded in 1993, the company was headquartered in Munich, Germany. | Health Technology |
- Borsa valori
- Insiders
- Regine Brokamp
- Esperienza